Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medmix AGMDMXF 68 Cash Ratio is 0.59 as of Jun. 2026, which is 8% below its 10-year median of 0.64. GuruFocus rates MDMXF with a GF Score™ of 68/100 and a GF Value™ of $17.95. The stock has 6 warning signs investors should review. Among 3,033 Industrial Products companies, Medmix AG ranks better than 54.2% on this metric.
Medmix AG has a Cash Ratio of 0.59. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Medmix AG's Cash Ratio or its related term are showing as below:
MDMXF'
s Cash Ratio Range Over the Past 10 Years
Min: 0.32 Med: 0.64 Max: 1.79
Current: 0.59
During the past 8 years, Medmix AG's highest Cash Ratio was 1.79. The lowest was 0.32. And the median was 0.64.
MDMXF's Cash Ratio is ranked better than 54.2% of 3033
companies
in the Industrial Products industry
Industry Median: 0.52
vs MDMXF: 0.59
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Medmix AG Cash Ratio Related Terms
Medmix AG Cash Ratio Historical Data
* Premium members only.
The historical data trend for Medmix AG's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Industrial Machinery subindustry, Medmix AG's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG Cash Ratio vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Medmix AG's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medmix AG (MDMXF) has a Cash Ratio of 0.59 as of Jun. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Medmix AG and its competitors. This is near median its historical median of 0.64. Over the past decade, Medmix AG's Cash Ratio has ranged from 0.32 to 1.79. According to the industry distribution chart, Medmix AG ranks #1389 out of 3033 companies in the Industrial Products industry, placing it in the top 45.8%.
Is Medmix AG's Cash Ratio too high?
Medmix AG's current Cash Ratio of 0.59 is near median its 10-year median of 0.64. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 1.79. The Industrial Products industry median Cash Ratio is 0.52. Medmix AG's value of 0.59 is 13.5% above this industry median. Based on the distribution chart, Medmix AG ranks #1389 out of 3033 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Medmix AG has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's Cash Ratio compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #1389 out of 3033 companies for Cash Ratio. This puts Medmix AG in the upper half of its industry. The industry median Cash Ratio is 0.52. Medmix AG's value of 0.59 is 13.5% above this benchmark. Historically, Medmix AG's own Cash Ratio has ranged from 0.32 to 1.79 over the past decade. While the company's 10-year median is 0.64 vs. the industry median of 0.52, Medmix AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for an Industrial Products company?
The median Cash Ratio among Industrial Products companies is 0.52, based on 3,033 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medmix AG's current Cash Ratio of 0.59 is 13.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Medmix AG and its competitors. For the Industrial Products industry, the median Cash Ratio is 0.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medmix AG's current Cash Ratio is 0.59, which is near median its own 10-year median of 0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Medmix AG (MDMXF) has a current Cash Ratio of 0.59. The stock's GF Value™ is $17.95, compared to a current price of $17.40 — trading 3.1% below its estimated fair value. The current Cash Ratio is 0.59, which is near median its 10-year median of 0.64 and 13.5% above the Industrial Products industry median of 0.52. Medmix AG's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Medmix AG (MDMXF), the current Cash Ratio is 0.59 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (MDMXF) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued.
The current stock price of $17.40 is trading 3.1% below its estimated GF Value™ of $17.95.
Key valuation signals for MDMXF:
Cash Ratio: 0.59 (near median its 10-year median of 0.64)
GF Value™: $17.95 vs. price of $17.40 (3.1% below fair value)
Industry Position: 13.5% above the Industrial Products median (#1389 of 3033)
No single metric tells the full story. See the MDMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
68GF Score
Get the complete analysis for MDMXF
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDMXF has been successfully added to your 
